RWA
NVO

Redmont Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Redmont Wealth Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$13.6K Hold
268
– – 0.02% 156
2025
Q3 		$14.9K Hold
268
– – 0.02% 158
2025
Q2 		$18.5K Buy
+268
New +$18.2K 0.03% 146
2024
Q4 		– Sell
-268
Closed -$31.9K – 224
2024
Q3 		$31.9K Hold
268
– – 0.05% 111
2024
Q2 		$38.3K Hold
268
– – 0.06% 98
2024
Q1 		$34.4K Buy
+268
New +$31.9K 0.05% 111

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Redmont Wealth Advisors's NVO Position: Q4 2025 in Review

Redmont Wealth Advisors held its Novo Nordisk (NVO) position steady in Q4 2025 at 268 shares worth $13.6K. The position accounts for 0.02% of the portfolio, ranked #156.

Redmont Wealth Advisors first reported a position in NVO in Q1 2024 and has held it in 6 quarters since. The position peaked at $38.3K in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Redmont Wealth Advisors held 268 shares of Novo Nordisk worth $13.6K as of Q4 2025.
  • Redmont Wealth Advisors left its Novo Nordisk share count unchanged in Q4 2025.
  • Novo Nordisk made up 0.02% of Redmont Wealth Advisors's portfolio in Q4 2025, its #156 holding.
  • Redmont Wealth Advisors first reported a position in Novo Nordisk in Q1 2024 and has held it in 6 quarters since.
  • Redmont Wealth Advisors's Novo Nordisk position peaked at $38.3K in Q2 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Redmont Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.